As research continues into how AI will impact practice, there are open questions about medical training, regulation, and more ...
Doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an AI model developed at ...
Unlike any single-lead or 6-lead consumer device, HeartBeam’s patented cable-free technology captures the heart’s electrical signals in three non-coplanar dimensions and synthesizes them into a ...
Press Trust of India on MSN
OMRON Healthcare unveils global ECG strategy
OMRON Healthcare Co., Ltd. announced new initiatives to accelerate its global electrocardiogram (ECG) business strategy, ...
TipRanks on MSN
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal
HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) clearance for its 12-lead ECG synthesis software for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results